On July 9, 2020, ASK Health and Health Work will be hosting a virtual roadshow. With support from ACCESS Health International Southeast Asia, five Southeast Asian healthcare companies have been invited to present their businesses, which range from implementing world-class genomic technologies (Asia Genomics), human analytics platform for the healthcare industry (Detalytics), real-world evidence platform for mental health (Holmusk), wearable robotic solutions for the disabled (Roceso Technologies), and transforming community care with innovative care models and technology (Tetsuyu Healthcare). The event will also feature Health Catalyst, the first healthcare big data innovation company successfully listed on Nasdaq, to give a keynote speech.
Agenda
14:00 – 14:15 Speech by the Xiang’an district government, Xiamen City
14:15 – 14:30 Keynote speech by Health Catalyst
14:30 – 16:10 Roadshow and Q&A
Please register at http://lxi.me/1xeru
You are also welcomed to join the roadshow via Zoom:
https://zoom.com.cn/j/61594725392?pwd=M2lNc0V6L1NocnNGWFFPTnZuVXpNdz09
ID：615 9472 5392
Password：063564
For inquiries, please contact [email protected]
Keynote Speaker:
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed. In July 2019, Health Catalyst became the first healthcare data provider to be listed on the Nasdaq Global Market.
Roadshow Speakers:
Formed by a team with diverse expertise, Asia Genomics focuses on implementing world-class genomic technologies to connect researchers, healthcare professionals, companies and consumers with forefront, reliable and affordable genetic tests. Asia Genomics advocates and educates physicians and patients through an outlined journey of genomics testing, integrates revolutionary scientific approach with medical and technology partners to help transform the future of healthcare in Asia.
Detalytics has created analytics products specifically to help organizations augment and optimize workforce management with ready-use data analytics. We have over two decades of combined experience in clinical research, software engineering, data analytics and business development across high-growth organizations around the world. We are supported by international advisors with expertise in human factors, sports science, aviation, performance management, extreme medicine, resilience training, the military and education, among others.
Mental health disorders remain the highest unmet medical need, surpassing cardiovascular disease, diabetes and cancer. Cumulative economic burden exceeds 16 trillion USD in direct and indirect costs. At Holmusk, we are addressing this problem by building the world’s largest Real-World Evidence (RWE) platform for mental health to deliver clinical and regulatory grade evidence to all major stakeholders of the healthcare ecosystem.
Roceso Technologies is a Singapore based medical device company offering wearable robotic solutions to bring independence and dignity back to lives of people with neurological disorders and disabilities through innovations and technologies. The soft robotic hand rehabilitation glove EsoGlove developed by Roceso Technologies utilizes bio-compatible soft materials and provides safe and comfortable repetitive trainings, individual finger exercises as well as functional task trainings.
A HealthTech start-up based in Singapore, Tetsuyu is co-founded by Dr Shinsuke Muto, a Japanese cardiologist and home care specialist and Ms Ng Li Lian, a former senior banker. At Tetsuyu, we want to transform community care with innovative care models and technology. This means bringing to market care solutions to improve access, productivity, quality and value.
